MK-886 is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist.
MoreFenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.
MoreBezafibrate is the first clinically tested dual and pan-PPAR co-agonism.
MoreCiprofibrate is a peroxisome proliferator-activated receptor agonist.
MoreRosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
MoreMK-886 is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist.
MoreFenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.
MoreBezafibrate is the first clinically tested dual and pan-PPAR co-agonism.
MoreCiprofibrate is a peroxisome proliferator-activated receptor agonist.
MoreRosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
More